Qualcomm Life Fund [QLF], a healthcare fund run by US-based semiconductor company Qualcomm’s corporate venturing unit, has sealed its eighth deal. Qualcomm Life Fund, managed by Qualcomm Ventures, has backed GoBalto, a US-based clinical study startup, as part of a $12m round. The series B round was led by EDBI, the investment unit of Singapore’s Economic Development Board. GoBalto’s flagship product is Tracker, – a clinical research tool which allows clinical trial sponsors and research organizations to study patients. The round included existing investors, West Health Investment Fund, part of healthcare cost reduction-focused organisation West Health, and venture firm Aberdare Ventures, as well as GoBalto’s founding chief executive Jae Chung. The round takes GoBalto to $21m raised. Jack Young, director of Qualcomm Ventures, said: “The cost of clinical development has been on the rise at an alarming rate in recent years. Adopting digital and mobile technologies could potentially increase the efficiency and reduce errors. Qualcomm together with a growing number of eco-system partners which offer a variety of wireless health solutions are well-positioned to help the industry. We see synergy by teaming with GoBalto.” Young added: “The QLF builds an investment thesis by identifying a number of verticals with strong and sustainable drivers, right market timing, and massive adoption potential where we look for investment. Currently the verticals we are focusing on are: wellness/fitness, chronicle disease management, aging-in-place, transitional care, clinical trial and telemedicine/telehealth.” GoBalto was founded in 2008 in Silicon Valley by Jae Chung. Last year GoBalto raised $8.5m, according to two filings with US regulator Securities and Exchange Commission.
- News & Analysis
- Global Corporate Venturing
- Global University Venturing
- Latest News
- Deal Data
- Community & Events
Qualcomm Life Fund seals eighth deal
Dec 28, 2012 • Toby Lewis
LEADERSHIP SOCIETYInforming, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
Featured ContentFUNDING ROUND DATA Which corporates are backing which startups? Search our corporate deal database.
FUNDING ROUND DATA
Which corporates are backing which startups? Search our corporate deal database.NOMINATE Nominations for the GCV Powerlist 2024 are now open
Nominations for the GCV Powerlist 2024 are now openEventsWebinar: Startups and Strategics – What works and what doesn’tEventsGCV Institute: Landing the Value of Corporate VenturingTop News
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.test reg